Kevin Chou
Examiner (ID: 9940)
Most Active Art Unit | 3785 |
Art Unit(s) | 3785 |
Total Applications | 4 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14471001
[patent_doc_number] => 20190187143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Compositions and Methods to Detect Head and Neck Cancer
[patent_app_type] => utility
[patent_app_number] => 16/224974
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224974 | Compositions and methods to detect head and neck cancer | Dec 18, 2018 | Issued |
Array
(
[id] => 14435671
[patent_doc_number] => 20190175707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/219520
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/219520 | CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF | Dec 12, 2018 | Pending |
Array
(
[id] => 14838899
[patent_doc_number] => 20190277850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHOD OF EVALUATING DRUG RESISTANCE AND TREATMENT EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/209907
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16209907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/209907 | Method of evaluating drug resistance and treatment effect | Dec 3, 2018 | Issued |
Array
(
[id] => 14583943
[patent_doc_number] => 20190219580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => METHODS OF DRUG THERAPY SELECTION FOR BREAST CANCER PATIENTS BASED ON HER2 AND HER3 PATHWAY SUBTYPING
[patent_app_type] => utility
[patent_app_number] => 16/202799
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202799 | METHODS OF DRUG THERAPY SELECTION FOR BREAST CANCER PATIENTS BASED ON HER2 AND HER3 PATHWAY SUBTYPING | Nov 27, 2018 | Abandoned |
Array
(
[id] => 13989987
[patent_doc_number] => 20190064151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => METHODS TO DETECT NON-GENOTOXIC CARCINOGENS USING FLATWORMS
[patent_app_type] => utility
[patent_app_number] => 16/176508
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176508 | METHODS TO DETECT NON-GENOTOXIC CARCINOGENS USING FLATWORMS | Oct 30, 2018 | Abandoned |
Array
(
[id] => 13990001
[patent_doc_number] => 20190064158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => MICROFLUIDIC DEVICE, SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/169738
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16169738
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/169738 | MICROFLUIDIC DEVICE, SYSTEM AND METHOD | Oct 23, 2018 | Abandoned |
Array
(
[id] => 17938448
[patent_doc_number] => 11472889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/159451
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33774
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159451 | Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof | Oct 11, 2018 | Issued |
Array
(
[id] => 18301087
[patent_doc_number] => 11622973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Immunomodulating compounds and related compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/151793
[patent_app_country] => US
[patent_app_date] => 2018-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 52
[patent_no_of_words] => 15472
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/151793 | Immunomodulating compounds and related compositions and methods | Oct 3, 2018 | Issued |
Array
(
[id] => 16665123
[patent_doc_number] => 10934356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Checkpoint blockade and microsatellite instability
[patent_app_type] => utility
[patent_app_number] => 16/144549
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 11526
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144549 | Checkpoint blockade and microsatellite instability | Sep 26, 2018 | Issued |
Array
(
[id] => 16254808
[patent_doc_number] => 20200264182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHOD FOR DETECTING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/644545
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644545 | METHOD FOR DETECTING PROSTATE CANCER | Sep 20, 2018 | Abandoned |
Array
(
[id] => 16114437
[patent_doc_number] => 20200209241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS OF CLASSIFYING RESPONSE TO IMMUNOTHERAPY FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/647434
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647434 | METHODS OF CLASSIFYING RESPONSE TO IMMUNOTHERAPY FOR CANCER | Sep 12, 2018 | Pending |
Array
(
[id] => 14040835
[patent_doc_number] => 20190076524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/124556
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/124556 | Constrained conditionally activated binding proteins | Sep 6, 2018 | Issued |
Array
(
[id] => 15135403
[patent_doc_number] => 10481162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Protein sequencing method and reagents
[patent_app_type] => utility
[patent_app_number] => 16/122558
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 14770
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122558 | Protein sequencing method and reagents | Sep 4, 2018 | Issued |
Array
(
[id] => 17605180
[patent_doc_number] => 11333659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Methods of measuring signaling pathway activity for selection of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 16/116392
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 57804
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 328
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116392 | Methods of measuring signaling pathway activity for selection of therapeutic agents | Aug 28, 2018 | Issued |
Array
(
[id] => 13829061
[patent_doc_number] => 20190018015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => COLORECTAL CANCER DIAGNOSTIC COMPOSITION, AND METHOD FOR DETECTING DIAGNOSTIC MARKER
[patent_app_type] => utility
[patent_app_number] => 16/111087
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16111087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/111087 | Colorectal cancer diagnostic composition, and method for detecting diagnostic marker | Aug 22, 2018 | Issued |
Array
(
[id] => 14075061
[patent_doc_number] => 20190086418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHOD FOR THE DIAGNOSIS OF ETOPOSIDE PRODRUG TREATABLE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/110007
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16110007
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/110007 | Method for the diagnosis of etoposide prodrug treatable cancer | Aug 22, 2018 | Issued |
Array
(
[id] => 13625393
[patent_doc_number] => 20180364248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => IGFBP-7 AS A MARKER OF PREECLAMPSIA
[patent_app_type] => utility
[patent_app_number] => 16/110687
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16110687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/110687 | IGFBP-7 as a marker of preeclampsia | Aug 22, 2018 | Issued |
Array
(
[id] => 16454002
[patent_doc_number] => 20200363428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
[patent_app_type] => utility
[patent_app_number] => 16/638878
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638878
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638878 | DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING | Aug 20, 2018 | Pending |
Array
(
[id] => 14263635
[patent_doc_number] => 10281376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => In situ heat induced antigen recovery and staining apparatus and method
[patent_app_type] => utility
[patent_app_number] => 16/102242
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 85
[patent_no_of_words] => 43254
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102242 | In situ heat induced antigen recovery and staining apparatus and method | Aug 12, 2018 | Issued |
Array
(
[id] => 13593107
[patent_doc_number] => 20180348102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => IN SITU HEAT INDUCED ANTIGEN RECOVERY AND STAINING APPARATUS AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/102166
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102166
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102166 | In situ heat induced antigen recovery and staining apparatus and method | Aug 12, 2018 | Issued |